levoleucovorin and Adenocarcinoma-of-Lung

levoleucovorin has been researched along with Adenocarcinoma-of-Lung* in 2 studies

Other Studies

2 other study(ies) available for levoleucovorin and Adenocarcinoma-of-Lung

Article	Year
Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report. BMC cancer, 2019, Jun-11, Volume: 19, Issue:1 We present the case of a 59 year old patient with a rare mutation in BRAF codon 594, who progressed rapidly on all classical therapies but experienced a clear and long lasting response on treatment with Regorafenib.. Little is known about therapies that can be effective in the rare Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carcinoembryonic Antigen; Cetuximab; Colonic Neoplasms; Exons; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mutation; Organoplatinum Compounds; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Pyridines; Tomography, X-Ray Computed; Treatment Outcome	2019
Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019, Volume: 14, Issue:10 Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorouracil; Hepatic Artery; Humans; Immunotherapy; Infusions, Intravenous; Leucovorin; Lung Neoplasms; Middle Aged; Nivolumab; Oxaliplatin; Prognosis; Radiosurgery	2019

Article

Year

Long term response on Regorafenib in non-V600E BRAF mutated colon cancer: a case report.

BMC cancer, 2019, Jun-11, Volume: 19, Issue:1

We present the case of a 59 year old patient with a rare mutation in BRAF codon 594, who progressed rapidly on all classical therapies but experienced a clear and long lasting response on treatment with Regorafenib.. Little is known about therapies that can be effective in the rare

Topics: Adenocarcinoma of Lung; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Biomarkers, Tumor; Carcinoembryonic Antigen; Cetuximab; Colonic Neoplasms; Exons; Fluorouracil; Follow-Up Studies; Humans; Leucovorin; Lung Neoplasms; Male; Middle Aged; Mutation; Organoplatinum Compounds; Phenylurea Compounds; Proto-Oncogene Proteins B-raf; Pyridines; Tomography, X-Ray Computed; Treatment Outcome

2019

Hepatic Intra-Arterial Chemotherapy With Immunotherapy in NSCLC.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2019, Volume: 14, Issue:10

Topics: Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Female; Fluorouracil; Hepatic Artery; Humans; Immunotherapy; Infusions, Intravenous; Leucovorin; Lung Neoplasms; Middle Aged; Nivolumab; Oxaliplatin; Prognosis; Radiosurgery

2019